Annual Total Liabilities
$23.18 M
+$7.04 M+43.56%
December 31, 2023
Summary
- As of February 7, 2025, SLNO annual total liabilities is $23.18 million, with the most recent change of +$7.04 million (+43.56%) on December 31, 2023.
- During the last 3 years, SLNO annual total liabilities has risen by +$3.75 million (+19.29%).
- SLNO annual total liabilities is now -41.23% below its all-time high of $39.45 million, reached on December 31, 2013.
Performance
SLNO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$32.01 M
+$8.63 M+36.93%
September 30, 2024
Summary
- As of February 7, 2025, SLNO quarterly total liabilities is $32.01 million, with the most recent change of +$8.63 million (+36.93%) on September 30, 2024.
- Over the past year, SLNO quarterly total liabilities has dropped by -$8.32 million (-20.63%).
- SLNO quarterly total liabilities is now -27.38% below its all-time high of $44.07 million, reached on September 30, 2014.
Performance
SLNO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SLNO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.6% | -20.6% |
| 3 y3 years | +19.3% | -20.6% |
| 5 y5 years | +82.0% | -20.6% |
SLNO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.6% | -20.6% | +99.0% |
| 5 y | 5-year | -0.2% | +43.6% | -20.6% | +99.0% |
| alltime | all time | -41.2% | +988.6% | -27.4% | +1402.9% |
Soleno Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $32.01 M(+36.9%) |
| Jun 2024 | - | $23.37 M(-8.2%) |
| Mar 2024 | - | $25.45 M(+9.8%) |
| Dec 2023 | $23.18 M(+43.6%) | $23.18 M(-42.5%) |
| Sep 2023 | - | $40.33 M(+117.8%) |
| Jun 2023 | - | $18.52 M(+9.6%) |
| Mar 2023 | - | $16.90 M(+4.6%) |
| Dec 2022 | $16.15 M(-9.1%) | $16.15 M(-3.8%) |
| Sep 2022 | - | $16.78 M(+1.4%) |
| Jun 2022 | - | $16.55 M(+2.9%) |
| Mar 2022 | - | $16.09 M(-9.4%) |
| Dec 2021 | $17.76 M(-8.6%) | $17.76 M(-20.6%) |
| Sep 2021 | - | $22.36 M(+4.8%) |
| Jun 2021 | - | $21.34 M(+11.5%) |
| Mar 2021 | - | $19.14 M(-1.5%) |
| Dec 2020 | $19.43 M(-16.3%) | $19.43 M(-18.3%) |
| Sep 2020 | - | $23.78 M(+4.8%) |
| Jun 2020 | - | $22.68 M(+0.2%) |
| Mar 2020 | - | $22.63 M(-2.6%) |
| Dec 2019 | $23.23 M | $23.23 M(+67.8%) |
| Sep 2019 | - | $13.84 M(-31.8%) |
| Jun 2019 | - | $20.29 M(+33.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $15.24 M(+19.6%) |
| Dec 2018 | $12.74 M(+4.4%) | $12.74 M(-23.4%) |
| Sep 2018 | - | $16.63 M(-5.0%) |
| Jun 2018 | - | $17.51 M(+31.5%) |
| Mar 2018 | - | $13.31 M(+9.1%) |
| Dec 2017 | $12.21 M(+473.1%) | $12.21 M(+284.8%) |
| Sep 2017 | - | $3.17 M(-14.1%) |
| Jun 2017 | - | $3.69 M(-0.8%) |
| Mar 2017 | - | $3.72 M(+74.7%) |
| Dec 2016 | $2.13 M(-57.2%) | $2.13 M(-18.0%) |
| Sep 2016 | - | $2.60 M(-11.2%) |
| Jun 2016 | - | $2.92 M(-17.7%) |
| Mar 2016 | - | $3.56 M(-28.6%) |
| Dec 2015 | $4.98 M(-74.6%) | $4.98 M(-42.0%) |
| Sep 2015 | - | $8.58 M(-47.7%) |
| Jun 2015 | - | $16.40 M(-23.2%) |
| Mar 2015 | - | $21.37 M(+9.1%) |
| Dec 2014 | $19.59 M(-50.4%) | $19.59 M(-55.6%) |
| Sep 2014 | - | $44.07 M(+4.2%) |
| Jun 2014 | - | $42.28 M(+6.5%) |
| Mar 2014 | - | $39.72 M(+0.7%) |
| Dec 2013 | $39.45 M(+7.5%) | $39.45 M |
| Dec 2012 | $36.71 M | - |
FAQ
- What is Soleno Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Soleno Therapeutics?
- What is Soleno Therapeutics annual total liabilities year-on-year change?
- What is Soleno Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly total liabilities year-on-year change?
What is Soleno Therapeutics annual total liabilities?
The current annual total liabilities of SLNO is $23.18 M
What is the all time high annual total liabilities for Soleno Therapeutics?
Soleno Therapeutics all-time high annual total liabilities is $39.45 M
What is Soleno Therapeutics annual total liabilities year-on-year change?
Over the past year, SLNO annual total liabilities has changed by +$7.04 M (+43.56%)
What is Soleno Therapeutics quarterly total liabilities?
The current quarterly total liabilities of SLNO is $32.01 M
What is the all time high quarterly total liabilities for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly total liabilities is $44.07 M
What is Soleno Therapeutics quarterly total liabilities year-on-year change?
Over the past year, SLNO quarterly total liabilities has changed by -$8.32 M (-20.63%)